Guo L - Search Results

1

Angiopoietin-2 (Ang-2) is a useful serum tumor marker for liver cancer in the Chinese population.

Chen Y, Wu Y, Zhang X, Zeng H, Liu Y, Wu Q, Chen Y, Zhu G, Pan Q, Jin L, Guo L, Sun F. Chen Y, et al. Among authors: guo l. Clin Chim Acta. 2018 Mar;478:18-27. doi: 10.1016/j.cca.2017.12.017. Epub 2017 Dec 15. Clin Chim Acta. 2018. PMID: 29253494

2

Serum 3'-sulfo-Lea indication of gastric cancer metastasis.

Zheng J, Bao WQ, Sheng WQ, Guo L, Zhang HL, Wu LH, Wu XZ. Zheng J, et al. Among authors: guo l. Clin Chim Acta. 2009 Jul;405(1-2):119-26. doi: 10.1016/j.cca.2009.04.017. Epub 2009 Apr 24. Clin Chim Acta. 2009. PMID: 19394320

3

Diagnostic value of serum tumor-associated autoantibodies in esophageal cancer.

Xiao K, Ma X, Wang Y, Zhu C, Guo L, Lu R. Xiao K, et al. Among authors: guo l. Biomark Med. 2021 Oct;15(15):1333-1343. doi: 10.2217/bmm-2021-0351. Epub 2021 Sep 20. Biomark Med. 2021. PMID: 34541870 Free article.

4

A combined strategy of TK1, HE4 and CA125 shows better diagnostic performance than risk of ovarian malignancy algorithm (ROMA) in ovarian carcinoma.

Zhu C, Zhang N, Zhong A, Xiao K, Lu R, Guo L. Zhu C, et al. Among authors: guo l. Clin Chim Acta. 2022 Jan 1;524:43-50. doi: 10.1016/j.cca.2021.11.018. Epub 2021 Nov 20. Clin Chim Acta. 2022. PMID: 34813778 Free article.

5

Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer.

Lu R, Sun M, Feng J, Gao X, Guo L. Lu R, et al. Among authors: guo l. BMC Cancer. 2011 Jun 25;11:270. doi: 10.1186/1471-2407-11-270. BMC Cancer. 2011. PMID: 21702971 Free PMC article.

6

[Expression of a novel biomarker, MR-1S, in ovarian carcinoma and its biological significance].

Lu RQ, Sun M, Gao X, Guo L. Lu RQ, et al. Among authors: guo l. Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):176-81. doi: 10.3760/cma.j.issn.0253-3766.2012.03.004. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22780969 Chinese.

7

Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis.

Lu R, Jiang M, Chen Z, Xu X, Hu H, Zhao X, Gao X, Guo L. Lu R, et al. Among authors: guo l. PLoS One. 2013 Sep 23;8(9):e74853. doi: 10.1371/journal.pone.0074853. eCollection 2013. PLoS One. 2013. PMID: 24086384 Free PMC article.

8

HE4 as a serum biomarker for ROMA prediction and prognosis of epithelial ovarian cancer.

Chen WT, Gao X, Han XD, Zheng H, Guo L, Lu RQ. Chen WT, et al. Among authors: guo l. Asian Pac J Cancer Prev. 2014;15(1):101-5. doi: 10.7314/apjcp.2014.15.1.101. Asian Pac J Cancer Prev. 2014. PMID: 24528007 Free article.

9

SIRT7 Exhibits Oncogenic Potential in Human Ovarian Cancer Cells.

Wang HL, Lu RQ, Xie SH, Zheng H, Wen XM, Gao X, Guo L. Wang HL, et al. Among authors: guo l. Asian Pac J Cancer Prev. 2015;16(8):3573-7. doi: 10.7314/apjcp.2015.16.8.3573. Asian Pac J Cancer Prev. 2015. PMID: 25921180 Free article.

10

Development of a multi-marker model combining HE4, CA125, progesterone, and estradiol for distinguishing benign from malignant pelvic masses in postmenopausal women.

Zhang P, Wang C, Cheng L, Zhang P, Guo L, Liu W, Zhang Z, Huang Y, Ou Q, Wen X, Tian Y. Zhang P, et al. Among authors: guo l. Tumour Biol. 2016 Feb;37(2):2183-91. doi: 10.1007/s13277-015-4037-3. Epub 2015 Sep 9. Tumour Biol. 2016. PMID: 26349751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,782 results

Search Page

Filters